pCCLCHIM-p47 (Lentiviral Vector Transduced CD34 Plus Cells) in Patients With p47 Autosomal Recessive Chronic Granulomatous Disease (AR-CGD)
type: MedicalStudy
description: A Phase I/II, Non-Randomized, Open-Label Study of pCCLCHIM-p47 (Lentiviral Vector Transduced CD34+ Cells) in Patients With p47 Autosomal Recessive Chronic Granulomatous Disease (AR-CGD)
status: ENROLLING_BY_INVITATION
study design: INTERVENTIONAL
phase: PHASE1,PHASE2
start date: 2024-06-25
end date: 2027-03-31
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT06253507
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
study subject: p47
study subject: Autosomal Recessive
study subject: Chronic Granulomatous Disease
keywords: PHASE1,PHASE2
keywords: INTERVENTIONAL
keywords: ENROLLING_BY_INVITATION
keywords: p47
keywords: Autosomal Recessive
keywords: Chronic Granulomatous Disease

AI Analytics
type: Organization